Previous close | 113.48 |
Open | 113.28 |
Bid | 113.86 x 1000 |
Ask | 113.90 x 800 |
Day's range | 112.93 - 114.02 |
52-week range | 89.67 - 121.64 |
Volume | |
Avg. volume | 5,718,765 |
Market cap | 197.221B |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | 34.87 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.20 (1.94%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | N/A |
Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
In the closing of the recent trading day, Abbott (ABT) stood at $111.50, denoting a +1.35% change from the preceding trading day.
Zacks.com users have recently been watching Abbott Laboratories (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.